Crofelemer has been granted Orphan Drug Designation by the U.S. Food and Drug Administration (FDA) and the European Medicines Agency for SBS and MVID. In October 2025, as announced, the company ...
A 13-year-old girl was rushed to Bnei Zion Medical Center in Haifa after experiencing difficulty swallowing, where doctors ...
The Crohn's & Colitis Foundation revealed compelling new research pointing to major health care access challenges and ...
Young people with ulcerative colitis face insurance-driven treatment delays, demanding early support for patients to manage ...
Young adults were also more likely to need to hustle for cash to cover their IBD care expenses, the survey found. About 18% ...
News-Medical.Net on MSN
Research points to major healthcare access challenges faced by young adults with IBD
The Crohn's & Colitis Foundation today revealed compelling new research pointing to major healthcare access challenges and ...
Jaguar Health (JAGX) announced that an article published December 29, 2025 in HEALTH, a bi-monthly English and Arabic healthcare magazine in the ...
Here are the 10 gastroenterology stories published by Becker’s that drew the most clicks this year: 10. Jacksonville, Fla.-based Borland Groover appointed four new C-suite leaders as part of a ...
Article discusses results demonstrating parenteral support (PS) reduction ranging from 12 to 37% in ongoing proof-of-concept study of crofelemer in pediatric patients with intestinal failureAssociated ...
New U.S. News & World Report rankings place Primary Children’s among the nation’s best, with top-50 recognition in all 11 ...
The Crohn’s & Colitis Foundation today revealed compelling new research pointing to major healthcare access challenges and financial burdens disproportionately affecting young adults with Inflammatory ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback